Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation

[1]  A. Wolk,et al.  Are increased levels of systemic oxidative stress and inflammation associated with age-related cataract? , 2014, Antioxidants & redox signaling.

[2]  R. Sihota,et al.  Evaluation of Oxidative Stress Markers in Aqueous Humor of Primary Open Angle Glaucoma and Primary Angle Closure Glaucoma Patients , 2014, Current eye research.

[3]  A. Alver,et al.  Serum Anti-carbonic Anhydrase Antibodies and Oxidant–Antioxidant Balance in Patients with Acute Anterior Uveitis , 2014, Ocular immunology and inflammation.

[4]  C. Erb,et al.  Hornhautendothelzelldichte in Abhängigkeit vom Schweregrad der Pseudoexfoliation , 2014, Klin Monatsbl Augenheilkd.

[5]  S. Guzel,et al.  What is the Effect of Pseudoexfoliation Syndrome on Renal Function in Patients without Glaucoma? , 2014, Current eye research.

[6]  U. Mazurek,et al.  Quantitative analysis of SOD2, ALDH1A1 and MGST1 messenger ribonucleic acid in anterior lens epithelium of patients with pseudoexfoliation syndrome , 2013, Molecular vision.

[7]  S. Neşelioğlu,et al.  Oxidative Stress and Anti-oxidative Defence in Patients with Age-related Macular Degeneration , 2013, Current eye research.

[8]  S. Akyol,et al.  Augmentation of ADAMTS9 gene expression by IL‐1β is reversed by NFκB and MAPK inhibitors, but not PI3 kinase inhibitors , 2012, Cell biochemistry and function.

[9]  M. Tosun,et al.  Aqueous humour and serum concentration of asymmetric dimethyl arginine in pseudoexfoliation syndrome , 2012, British Journal of Ophthalmology.

[10]  M. Tarpey,et al.  Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production. , 2011, Free radical biology & medicine.

[11]  M. Pinazo-Durán,et al.  Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy , 2011, Molecular vision.

[12]  A. Gürel,et al.  The Activities of Paraoxonase, Xanthine Oxidase, Adenosine Deaminase and the Level of Nitrite in Pseudoexfoliation Syndrome , 2009, Ophthalmic Research.

[13]  A. Struthers,et al.  Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress , 2009, Vascular health and risk management.

[14]  D. Pahor,et al.  Systemische Endotheldysfunktion bei Patienten mit Pseudoexfoliationssyndrom , 2008, Klinische Monatsblatter fur Augenheilkunde.

[15]  E. Asprodini,et al.  In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. , 2007, Biomedical chromatography : BMC.

[16]  Z. Yousefipour,et al.  Oxidative Stress-Associated Vascular Aging Is Xanthine Oxidase-Dependent but not NAD(P)H Oxidase-Dependent , 2006, Journal of cardiovascular pharmacology.

[17]  L. Žorić,et al.  Pseudoexfoliation Syndrome and its Antioxidative Protection Deficiency as Risk Factors for Age-Related Cataract , 2006, European journal of ophthalmology.

[18]  P. Brown,et al.  Differential gene expression in anatomical compartments of the human eye , 2005, Genome Biology.

[19]  J. Hare,et al.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications , 2004, The Journal of physiology.

[20]  M. Ingelman-Sundberg,et al.  Xanthine oxidase activity is influenced by environmental factors in Ethiopians , 2003, European Journal of Clinical Pharmacology.

[21]  U. Schlötzer-Schrehardt,et al.  Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. , 2001, Experimental eye research.

[22]  U. Schlötzer-Schrehardt,et al.  Transforming and insulin-like growth factors in the aqueous humour of patients with exfoliation syndrome , 2001, Graefe's Archive for Clinical and Experimental Ophthalmology.

[23]  U. Schlötzer-Schrehardt,et al.  Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. , 1994, German journal of ophthalmology.

[24]  M. Relling,et al.  Racial and gender differences in N‐acetyltransferase, xanthine oxidase, and CYP1A2 * activities , 1992, Clinical pharmacology and therapeutics.

[25]  R. Eagle,et al.  Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. , 1992, Archives of ophthalmology.

[26]  R. Weinshilboum,et al.  Human liver xanthine oxidase: Nature and extent of individual variation , 1991, Clinical pharmacology and therapeutics.

[27]  V. Kinsey.  Transfer of ascorbic acid and related compounds across the blood-aqueous barrier. , 1947, American journal of ophthalmology-glaucoma.

[28]  U. Schlötzer-Schrehardt,et al.  [Corneal endothelial cell density and its correlation with the severity of pseudoexfoliation]. , 2014, Klinische Monatsblatter fur Augenheilkunde.

[29]  Filiz Yildirim,et al.  The role of the cytokines in the pathogenesis of pseudoexfoliation syndrome. , 2013, International journal of ophthalmology.

[30]  A. Gürel,et al.  Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome , 2008, Eye.

[31]  N. Ozer,et al.  Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. , 2006, International heart journal.

[32]  Stefan D Anker,et al.  Uric acid in chronic heart failure. , 2005, Seminars in nephrology.

[33]  K. Mark,et al.  DIFFERENTIAL GENE EXPRESSION IN PSEUDO EXFOLIATION SYNDROME , 2005 .

[34]  D. Harman.  Free radical involvement in aging. Pathophysiology and therapeutic implications. , 1993, Drugs & aging.

[35]  D. Harman.  Free Radical Involvement in Aging , 1993 .

[36]  D. Granger,et al.  Xanthine oxidase: biochemistry, distribution and physiology. , 1986, Acta physiologica Scandinavica. Supplementum.